These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 7328350
1. Immunopotentiating action of streptococcal preparation OK-432 and protein-bound polysaccharide PS-K on depressed state of cell-mediated and humoral immunities of Friend leukemia virus infected mice. Kiyohashi A. Nihon Gan Chiryo Gakkai Shi; 1981 Aug 20; 16(4):641-6. PubMed ID: 7328350 [No Abstract] [Full Text] [Related]
2. Protection by BCG, levamisole, PS-K, OK-432, and vitamin E against carbon tetrachloride hepatotoxicity. Yoshikawa T, Furukawa Y, Wakamatsu Y, Kondo M. Hepatogastroenterology; 1982 Dec 20; 29(6):240-2. PubMed ID: 7152457 [Abstract] [Full Text] [Related]
3. The augmentative effect of a protein-bound polysaccharide (PSK) on tumoricidal activity of the soluble factor produced by a streptococcal preparation (OK-432)-activated macrophages. Baba N, Kawami H, Sato Y, Takayama T, Toge T. Biotherapy; 1991 Dec 20; 3(4):359-64. PubMed ID: 1786200 [Abstract] [Full Text] [Related]
4. [Direct antitumor activity of biological response modifiers (B.R.M.) proven by an in vitro sensitivity test]. Yanagawa T, Oguro M, Takagi T, Takenaga K. Gan To Kagaku Ryoho; 1984 Oct 20; 11(10):2155-62. PubMed ID: 6486831 [Abstract] [Full Text] [Related]
10. [Correlation between enhancement of natural killer (NK) activity by an immunopotentiator (OK-432) and resistance to human hepatoma cell implantation in nude mice]. Saito H, Morizane T, Kumagai N, Inagaki Y, Nakamura T, Satoh I, Iino A, Matsumura S, Kawamura N, Tsuchiya M. Nihon Shokakibyo Gakkai Zasshi; 1985 Dec 20; 82(12):2923-9. PubMed ID: 3831444 [No Abstract] [Full Text] [Related]
11. [NK activities in cancer patients--their modification by an immunopotentiator]. Sasanami T, Fujishima A, Moriya Y, Imai K, Yachi A. Gan To Kagaku Ryoho; 1982 Dec 20; 9(12):2186-92. PubMed ID: 7184392 [Abstract] [Full Text] [Related]
12. [Immunopotentiation by OK-432 ointment to apply to the mouse abdominal skin]. Matsuoka H, Yano K, Baba H, Kounoe S, Seo Y, Saito T, Tomoda H, Wakasugi H. Gan To Kagaku Ryoho; 1995 Sep 20; 22(11):1644-6. PubMed ID: 7574783 [Abstract] [Full Text] [Related]
13. [Influence of immunopotentiators on the activation of 5-FU derivatives]. Nakazato H, Kito T, Yasue M, Yamamura Y, Kobari T, Hirakawa T, Hatta M. Gan To Kagaku Ryoho; 1985 Apr 20; 12(4):867-74. PubMed ID: 3920971 [Abstract] [Full Text] [Related]
15. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors. Wakasugi H, Oshimi K, Miyata M, Morioka Y. J Clin Immunol; 1981 Jul 20; 1(3):154-62. PubMed ID: 6174541 [Abstract] [Full Text] [Related]
16. Effect of biological response modifier-streptococcal preparation OK-432 on NK/K cell system of gnotobiotic miniature swine. Kim YB. Prog Clin Biol Res; 1985 Jul 20; 181():337-41. PubMed ID: 4063011 [No Abstract] [Full Text] [Related]
17. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)]. Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N. Gan To Kagaku Ryoho; 1982 Nov 20; 9(11):2031-7. PubMed ID: 6820888 [Abstract] [Full Text] [Related]
19. Anti-tumor effect of a streptococcal preparation (OK-432). 1. Positive co-relation between the anti-tumour effect and delayed type hypersensitivity reaction to OK-432 in mice. Makidono R, Matsuura K, Makidono A. Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Feb 25; 44(2):379-91. PubMed ID: 6477682 [No Abstract] [Full Text] [Related]
20. In vitro effect of murine peritoneal exudate cells activated with a streptococcal preparation, OK-432, on hematopoietic stem cells. Hiraoka A, Yamagishi M, Ohkubo T, Yoshida Y, Uchino H. Nihon Ketsueki Gakkai Zasshi; 1982 Feb 25; 45(1):82-90. PubMed ID: 6981281 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]